Disney Rides Rating Reiteration, Questcor Eyes Pilot Commercialization, and 3 More Hot Stocks to Check Out

Disney (NYSE:DIS): JPMorgan has reinforced its Overweight rating on Disney, helping drive shares over 2 percent. Though the Lone Ranger flick hasn’t quite met analyst expectations at the box office, Disney has such strong films in the pipeline that the long-term outlook is as positive and confident as ever, even if it ends up taking a charge in the fourth quarter due to Ranger‘s failure to meet its budget.


Questcor Pharmaceuticals (NASDAQ:QCOR): The company is apparently ”experiencing solid uptake” of its Acthar Gel in the area of rheumatology, including “a larger than expected number of prescriptions for rheumatoid arthritis.” Questcor now hopes to speed up its pilot commercialization of Acthar for patients who suffer respiratory problems from the autoimmune disease symptomatic sarcoidosis, starting with plans to hire a sales team of five to 10 people and contact pulmonologists in the fourth quarter.


BlackBerry (NASDAQ:BBRY): The Wall Street Journal reported a handful of executive departures Wednesday evening, with social networking head T.A. McCann and calendar and contacts app chief Marc Gingras both leaving the company. However, despite the recent layoffs and firings, BlackBerry reportedly “tried to convince both men to stay.”


Aetna, Inc. (NYSE:AET): Aetna has formed an alliance with Swiss Life Holding, in a deal that will allow Aetna to provide products and services to Swiss Life’s multinational customers to meet the needs of their U.S. employees — especially those who work abroad. Additionally, Swiss Life will offer Aetna’s group term life insurance coverage, short- and long-term disability coverage, and short-term international health coverage for business travelers.


Advanced Micro Devices (NYSE:AMD): Shares of AMD are on a tear, up over 10 percent, following two upgrades: Bank of America/Merrill Lynch jacked up its rating two notches, from Sell to Buy, and Canaccord also raised the firm to a Buy with a $5 price target, up from $3.


Don’t Miss: SoftBank Can Now Begin Work on Sprint.